Dylan Kennett – DLA Piper

Senior Associate

Dylan is a Senior Associate in the London Corporate department of DLA Piper.  He has deep expertise in venture capital, as well as domestic and cross-border mergers & acquisitions and private equity transactions.  He is a trusted advisor for fast growing companies and helping them ‘go global’. His practice encompasses the cannabis, life sciences, technology, media and sport sectors.

Dylan is Co-Head of DLA Piper’s Global Cannabis Practice. The practice sits as a sub-group under the firm’s Life Sciences sector and provides full-service advice with specialist cannabis sector knowledge in over 20 countries globally across DLA Piper.  The practice serves cannabis clients across a wide spectrum of issues, but has particular expertise in cross-border M&A, private and public equity financing, as well as deep expertise in the rapidly evolving global regulatory frameworks.

Dylan is also a Co-Head of DLA Piper’s Emerging Growth and Venture Capital practice.  He has a wealth of experience in advising high growth companies in relation to their fundraising activities, as well as acting for investors, particular corporate venture arms, on their strategic investments and R&D.

Recent Articles

Key Matters

  • Robin Emerson on branding and licensing agreement with leading CBD API company Brains Bioceutical, that will see his daughter’s name used in a new line of CBD products.  DLA Piper also advised Robin as new head of Corporate Social Responsibility at Brains.
  • Hanway Associates, the cannabis consultancy business, on the sale of HAPP Holdings Limited to NOBL Group, including the market leading conference series Cannabis Europa.
  • Avicanna, a medicinal cannabis licenced producer, on all aspects of their global expansion.
  • Phytome Life Sciences, a medicinal cannabis R&D company, on all aspects of their business from their startup financing, regulatory and all other day to day matters.
  • Materia Ventures on its European expansion plans.
  • Charlotte’s Web, one of the leading CBD brands, on their expansion globally.
  • Pet Releaf, a leading pet health company, focussed on cannabis-infused products for animals, on their global expansion.


Address & Contacts


160 Aldersgate Street London EC1A 4HT United Kingdom


51.51894224845982, -0.09723968554187862